AT316753B - Verfahren zur Herstellung eines Fibrinolyseaktivators - Google Patents

Verfahren zur Herstellung eines Fibrinolyseaktivators

Info

Publication number
AT316753B
AT316753B AT840172A AT840172A AT316753B AT 316753 B AT316753 B AT 316753B AT 840172 A AT840172 A AT 840172A AT 840172 A AT840172 A AT 840172A AT 316753 B AT316753 B AT 316753B
Authority
AT
Austria
Prior art keywords
preparation
fibrinolysis activator
fibrinolysis
activator
Prior art date
Application number
AT840172A
Other languages
German (de)
English (en)
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Application granted granted Critical
Publication of AT316753B publication Critical patent/AT316753B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT840172A 1971-09-30 1972-09-29 Verfahren zur Herstellung eines Fibrinolyseaktivators AT316753B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2148865A DE2148865C3 (de) 1971-09-30 1971-09-30 Verwendung eines Streptokinase-Plasminogen-Komplexes zur Fibrinolyse

Publications (1)

Publication Number Publication Date
AT316753B true AT316753B (de) 1974-07-25

Family

ID=5821086

Family Applications (1)

Application Number Title Priority Date Filing Date
AT840172A AT316753B (de) 1971-09-30 1972-09-29 Verfahren zur Herstellung eines Fibrinolyseaktivators

Country Status (10)

Country Link
JP (1) JPS557408B2 (cg-RX-API-DMAC10.html)
AT (1) AT316753B (cg-RX-API-DMAC10.html)
BE (1) BE789596A (cg-RX-API-DMAC10.html)
CA (1) CA980689A (cg-RX-API-DMAC10.html)
CH (1) CH580963A5 (cg-RX-API-DMAC10.html)
DE (1) DE2148865C3 (cg-RX-API-DMAC10.html)
DK (1) DK133496C (cg-RX-API-DMAC10.html)
FR (1) FR2154756B1 (cg-RX-API-DMAC10.html)
GB (1) GB1384932A (cg-RX-API-DMAC10.html)
NL (1) NL156051B (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5659452A (en) * 1979-10-20 1981-05-22 Hitachi Maxell Ltd Manufacture of dry cell
DE4411143C2 (de) * 1994-03-30 1996-08-01 Immuno Ag Thrombosemittel
WO2008047669A1 (en) 2006-10-16 2008-04-24 Nippon Sheet Glass Company, Limited Glass with molding

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3019167A (en) * 1959-05-01 1962-01-30 Innerfield Irving Method of administering streptokinase systemically
US3274059A (en) * 1961-11-13 1966-09-20 Merck & Co Inc Stable-enhanced plasmin solutions

Also Published As

Publication number Publication date
NL7212945A (cg-RX-API-DMAC10.html) 1973-04-03
CH580963A5 (cg-RX-API-DMAC10.html) 1976-10-29
FR2154756A1 (cg-RX-API-DMAC10.html) 1973-05-11
JPS4840921A (cg-RX-API-DMAC10.html) 1973-06-15
GB1384932A (en) 1975-02-26
BE789596A (fr) 1973-04-02
DK133496B (da) 1976-05-31
DK133496C (da) 1976-10-18
DE2148865A1 (de) 1973-04-05
FR2154756B1 (cg-RX-API-DMAC10.html) 1976-04-23
DE2148865C3 (de) 1981-04-23
CA980689A (en) 1975-12-30
JPS557408B2 (cg-RX-API-DMAC10.html) 1980-02-25
DE2148865B2 (de) 1980-07-24
NL156051B (nl) 1978-03-15

Similar Documents

Publication Publication Date Title
AT320296B (de) Verfahren zur Herstellung eines Pulvers
AT318548B (de) Verfahren zur Herstellung eines Deshydratisierkatalysators
AT321456B (de) Verfahren zur Herstellung eines Enzympräparates
AT323628B (de) Verfahren zur herstellung eines gepressten gegenstandes
AT319259B (de) Verfahren zur Herstellung neuer Dihydropyridazone
CH535253A (de) Verfahren zur Herstellung von substituierten Benzthiazolen
AT321230B (de) Verfahren zur Herstellung eines Enzym-Tannin-Adduktes
AT315829B (de) Verfahren zur Herstellung von 4-Halogenmethylcumarinen
AT316753B (de) Verfahren zur Herstellung eines Fibrinolyseaktivators
AT312805B (de) Verfahren zur Herstellung eines Sekretin-Präparates
AT309679B (de) Verfahren zur Herstellung von 6-Desoxytetracyclinen
DD101403A5 (de) Verfahren zur herstellung von phenylimidazolidinonen
AT316706B (de) Verfahren zur Herstellung eines Überzugsmittels
AT305496B (de) Verfahren zur Herstellung eines blutstillenden Präparats
AT332538B (de) Verfahren zur herstellung eines 7beta-aminocephalosporins
AT324553B (de) Verfahren zur herstellung von 3-alkylthiomethylcephalosporinen
AT322734B (de) Verfahren zur herstellung von wasserlöslichen cephalosporin-ca-verbindungen
AT315368B (de) Verfahren zur Herstellung eines neuen Antibioticums
AT326816B (de) Verfahren zur herstellung von 3-carbamoyloxymethylcephalosporinverbindungen
CH537915A (de) Verfahren zur Herstellung eines neuen Östratriols
AT318555B (de) Verfahren zur Herstellung von Penicillamin
AT327910B (de) Verfahren zur herstellung von 5-acyl-iminostilben-derivaten
AT314736B (de) Verfahren zur herstellung eines lactulosepulvers
AT318823B (de) Verfahren zur Herstellung von 16-Carboxy-17-methoxy-eburnan
CH528533A (de) Verfahren zur Herstellung von Thiazylharnstoffen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee